Welcome to ATMP Sweden!
ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.
Who are we?
The ATMP Sweden network was founded through the Vinnova funded projects CAMP and Swelife-ATMP. The activity is now supported by the Vinnova funded ATMP Innovation Milieu. Other Swedish ATMP specific or relevant national networks fit under the ATMP Sweden umbrella including NextGenNK, GenNova, IndiCell and SWECARNET. ATMP Sweden provides support in communication, collaboration and network building. Learn more about these and other ATMP relevant initiatives!
News
2022-01-10
Sweden hosts world leaders in hPSC-ATMPs
Closed symposia on the challenges in development of hPSC-ATMP and collaborative potential to drive the field forwards
Read article
2021-12-28
Douglas Melton and a ’cure’ for type 1 diabetes
Karolinska Institutet hosts Doug Melton on ZOOM January 11th 2022
Read article
2021-12-20
Amniotics joins Vinnova funded ’CAMP’ project
Working towards improving outcomes of lung transplantations with PulmoStem
Read article
Download "Regulatory lessons COVID19 vaccines for gene therapy"
At ATMP Sweden 2021 Axel Ståhlbom summarised regulatory learnings from the approval of COVID19 vaccines and how this is relevant to the gene therapy/GTMP field. Download the slides on our ’What are ATMPs’ page!
Resources
Learn more about the Health Technology Assessment related issues of your ATMP development.
This guide will provide useful information and insights throughout the ATMP development process.
Find or advertise ATMP relevant job opportunities.
Conferences & events
Conference
ATMP Sweden 2022 Stockholm
29 August
Aula Medica, Nobels väg 6, Stockholm.
Organizer: ATMP Sweden
Fingers crossed for our physical conference to be held in the Spring of 2022!
Read more